The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

Over the last five years, billions of people have received at least one dose of a COVID-19 mRNA vaccine. New research has found an unanticipated result of these vaccines: Cancer treatments are more ...

The CDC has issued updated recommendations for the 2025–2026 COVID-19 vaccination season, covering mRNA and protein subunit vaccines for people aged 6 months and older. The new formulations target ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, a fierce debate has taken place around the future of mRNA-based vaccines ...

Breaking news headlines, stories and live updates on current affairs from across the globe. Complete coverage on the latest ...